Liquid Biopsy Market In 2022 : Research Insights with Upcoming Trends, Opportunities, Competitive Analysis, Forecast 2030
Global Liquid Biopsy Market Size and Revenue Forecasts
to 2030
The
global liquid
biopsy market size is expected to
reach USD 7,645.0 Million in 2030 and register a revenue CAGR of 20.3% over the
forecast period, according to the latest analysis by Emergen Research.. The
research study also provides a complete analysis of the market drivers,
restraints, limitations, threats, risks, and growth opportunities.
In
addition, growing popularity of non-invasive techniques is driving private and
public financing for research in the field of liquid biopsy, which allow
medical professionals to discover various aspects of a tumor through a
patient’s blood sample. Increased adoption of
liquid biopsy in cancer is due to its potential for non-invasive detection of
targeted genomic alteration in correspondence to targeted therapy.
Non-cancerous application of liquid biopsy includes diagnosis of heart attack
and atherosclerosis.
Academic
researchers from various areas of expertise are working on developing,
refining, and establishing clinical uses for liquid biopsy tests. For instance,
InterVenn Biosciences announced completion of USD 201 million Series C
financing in August 2021.
Get a sample of the report @ https://www.emergenresearch.com/request-sample/34
The
report offers a panoramic view of the competitive landscape of the industry and
a detailed analysis of the key players of the market based on their revenue,
profit margins, financial standing, global market position, R&D activities,
and product portfolio. It also covers their strategic endeavors such as mergers
and acquisitions, joint ventures, collaborations, partnerships, corporate and
government deals, and product launches and brand promotions, among others Some
companies in the global market report include Bio-Rad Laboratories, Inc.,
Adaptive Biotechnologies, NeoGenomics Laboratories, Guardant Health, Biocept,
Inc., QIAGEN, F. Hoffmann-La Roche Ltd., MDxHealth, Menarini Silicon
Biosystems, and Agena Bioscience, Inc.
Emergen
Research has segmented the global liquid biopsy market based on product type,
circulating biomarkers, sample type, technology, disease, application, end-use,
and region:
- Product Type
Outlook (Revenue, USD Million; 2019–2030)
- Assays Kits
- Instruments
- Services
- Circulating
Biomarkers Outlook (Revenue, USD Million; 2019–2030)
- Circulating
Tumor DNA (ctDNA)
- Circulating
Tumor Cells (CTCs)
- Extracellular
Vesicles (EVs)
- Cell-Free
DNA (cfDNA)
- Others
- Sample Type
Outlook (Revenue, USD Million; 2019–2030)
- Blood Sample
- Urine Sample
- Others
- Technology
Outlook (Revenue, USD Million; 2019–2030)
- Multi-gene-parallel
Analysis (NGS)
- Single Gene
Analysis (PCR Microarrays)
- Disease
Outlook (Revenue, USD Million; 2019–2030)
- Oncology
- Breast
Cancer
- Lung Cancer
- Prostate
Cancer
- Colorectal
Cancer
- Melanoma Cancer
- Others
- Non-cancer
- Application
Outlook (Revenue, USD Million; 2019–2030)
- Early Cancer
Screening
- Therapy
Selection
- Treatment
Monitoring
- Recurrence
Monitoring Orthopedics
- End-Use
Outlook (Revenue, USD Million; 2019–2030)
- Hospitals
& Physician Laboratories
- Reference
Laboratories
- Academic
& Research Centers
- Others
To know more about the report, visit @ https://www.emergenresearch.com/industry-report/liquid-biopsy-market
Regional Analysis of the Liquid Biopsy Market
Includes:
North
America (U.S., Canada)
Europe
(U.K., Italy, Germany, France, Rest of EU)
Asia
Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin
America (Chile, Brazil, Argentina, Rest of Latin America)
Middle
East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
The
report offers a complete understanding of the liquid biopsy market in key
regions with respect to regional production and consumption patterns,
import/export, supply and demand dynamics, trends, growth prospects, and the
presence of prominent players in each region. Each of the mentioned regions is
analyzed based on the comprehensive market data obtained from the major
countries of each region to impart a clear understanding of the market.
Request customization of the report @ https://www.emergenresearch.com/request-for-customization/34
Thank
you for reading our report. To request a customization or for further inquiries,
kindly get in touch with us. Our team will ensure the report is tailored meet
to your needs.
About Us:
Emergen Research is
a market research and consulting company that provides syndicated research
reports, customized research reports, and consulting services. Our solutions
purely focus on your purpose to locate, target, and analyse consumer behavior
shifts across demographics, across industries, and help clients make smarter
business decisions. We offer market intelligence studies ensuring relevant and
fact-based research across multiple industries, including Healthcare, Touch
Points, Chemicals, Types, and Energy. We consistently update our research
offerings to ensure our clients are aware of the latest trends existent in the
market. Emergen Research has a strong base of experienced analysts from varied
areas of expertise. Our industry experience and ability to develop a concrete
solution to any research problems provides our clients with the ability to
secure an edge over their respective competitors.
Contact Us:
Eric
Lee
Corporate
Sales Specialist
Emergen
Research | Web: www.emergenresearch.com
Direct
Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for
More Insights: https://www.emergenresearch.com/insights
Explore
Our Custom
Intelligence services | Growth
Consulting Services
Comments
Post a Comment